nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—hypertension—obesity	0.52	1	CtDrD
Guanabenz—ADRA2C—Methamphetamine—obesity	0.0624	0.186	CbGbCtD
Guanabenz—ADRA2B—Methamphetamine—obesity	0.0592	0.177	CbGbCtD
Guanabenz—ADRA2A—Benzphetamine—obesity	0.0515	0.154	CbGbCtD
Guanabenz—ADRA2A—Phenylpropanolamine—obesity	0.0492	0.147	CbGbCtD
Guanabenz—ADRA2A—Methamphetamine—obesity	0.0412	0.123	CbGbCtD
Guanabenz—CYP1A2—Phentermine—obesity	0.0208	0.0621	CbGbCtD
Guanabenz—CYP1A2—Phenylpropanolamine—obesity	0.0198	0.0593	CbGbCtD
Guanabenz—CYP1A2—Bupropion—obesity	0.0177	0.0528	CbGbCtD
Guanabenz—CYP1A2—Cimetidine—obesity	0.013	0.0388	CbGbCtD
Guanabenz—NISCH—islet of Langerhans—obesity	0.000292	0.13	CbGeAlD
Guanabenz—NISCH—adrenal cortex—obesity	0.000232	0.103	CbGeAlD
Guanabenz—NISCH—pituitary gland—obesity	0.000187	0.0831	CbGeAlD
Guanabenz—NISCH—adipose tissue—obesity	0.000186	0.0828	CbGeAlD
Guanabenz—NISCH—adrenal gland—obesity	0.000167	0.0742	CbGeAlD
Guanabenz—Haemorrhage—Bupropion—obesity	0.000136	0.00156	CcSEcCtD
Guanabenz—Malnutrition—Sibutramine—obesity	0.000136	0.00156	CcSEcCtD
Guanabenz—Back pain—Orlistat—obesity	0.000136	0.00156	CcSEcCtD
Guanabenz—Muscle spasms—Orlistat—obesity	0.000135	0.00155	CcSEcCtD
Guanabenz—Oedema peripheral—Bupropion—obesity	0.000134	0.00154	CcSEcCtD
Guanabenz—Flatulence—Sibutramine—obesity	0.000134	0.00154	CcSEcCtD
Guanabenz—Connective tissue disorder—Bupropion—obesity	0.000134	0.00154	CcSEcCtD
Guanabenz—Tension—Sibutramine—obesity	0.000133	0.00153	CcSEcCtD
Guanabenz—Vision blurred—Orlistat—obesity	0.000132	0.00152	CcSEcCtD
Guanabenz—Nervousness—Sibutramine—obesity	0.000132	0.00152	CcSEcCtD
Guanabenz—Vomiting—Cimetidine—obesity	0.000132	0.00152	CcSEcCtD
Guanabenz—Back pain—Sibutramine—obesity	0.000132	0.00151	CcSEcCtD
Guanabenz—Rash—Cimetidine—obesity	0.000131	0.0015	CcSEcCtD
Guanabenz—Dermatitis—Cimetidine—obesity	0.000131	0.0015	CcSEcCtD
Guanabenz—NISCH—liver—obesity	0.000131	0.058	CbGeAlD
Guanabenz—Muscle spasms—Sibutramine—obesity	0.000131	0.0015	CcSEcCtD
Guanabenz—Ill-defined disorder—Orlistat—obesity	0.00013	0.0015	CcSEcCtD
Guanabenz—Headache—Cimetidine—obesity	0.00013	0.00149	CcSEcCtD
Guanabenz—Nausea—Diethylpropion—obesity	0.00013	0.00149	CcSEcCtD
Guanabenz—Erythema multiforme—Bupropion—obesity	0.000129	0.00148	CcSEcCtD
Guanabenz—Hypoglycaemia—Topiramate—obesity	0.000129	0.00147	CcSEcCtD
Guanabenz—Angioedema—Orlistat—obesity	0.000128	0.00147	CcSEcCtD
Guanabenz—Vision blurred—Sibutramine—obesity	0.000128	0.00147	CcSEcCtD
Guanabenz—Eye disorder—Bupropion—obesity	0.000127	0.00146	CcSEcCtD
Guanabenz—Tinnitus—Bupropion—obesity	0.000127	0.00146	CcSEcCtD
Guanabenz—Malaise—Orlistat—obesity	0.000127	0.00145	CcSEcCtD
Guanabenz—Ill-defined disorder—Sibutramine—obesity	0.000126	0.00145	CcSEcCtD
Guanabenz—Hyponatraemia—Topiramate—obesity	0.000126	0.00144	CcSEcCtD
Guanabenz—Anaemia—Sibutramine—obesity	0.000126	0.00144	CcSEcCtD
Guanabenz—Agitation—Sibutramine—obesity	0.000125	0.00143	CcSEcCtD
Guanabenz—Angioedema—Sibutramine—obesity	0.000124	0.00143	CcSEcCtD
Guanabenz—Nausea—Cimetidine—obesity	0.000123	0.00142	CcSEcCtD
Guanabenz—Immune system disorder—Bupropion—obesity	0.000123	0.00141	CcSEcCtD
Guanabenz—Mediastinal disorder—Bupropion—obesity	0.000123	0.00141	CcSEcCtD
Guanabenz—Malaise—Sibutramine—obesity	0.000123	0.00141	CcSEcCtD
Guanabenz—Cough—Orlistat—obesity	0.000123	0.00141	CcSEcCtD
Guanabenz—Chills—Bupropion—obesity	0.000122	0.0014	CcSEcCtD
Guanabenz—Syncope—Sibutramine—obesity	0.000122	0.0014	CcSEcCtD
Guanabenz—Leukopenia—Sibutramine—obesity	0.000122	0.0014	CcSEcCtD
Guanabenz—Face oedema—Topiramate—obesity	0.000121	0.00139	CcSEcCtD
Guanabenz—Myalgia—Orlistat—obesity	0.00012	0.00137	CcSEcCtD
Guanabenz—Chest pain—Orlistat—obesity	0.00012	0.00137	CcSEcCtD
Guanabenz—Loss of consciousness—Sibutramine—obesity	0.00012	0.00137	CcSEcCtD
Guanabenz—Anxiety—Orlistat—obesity	0.000119	0.00137	CcSEcCtD
Guanabenz—Cough—Sibutramine—obesity	0.000119	0.00136	CcSEcCtD
Guanabenz—Malnutrition—Bupropion—obesity	0.000119	0.00136	CcSEcCtD
Guanabenz—Discomfort—Orlistat—obesity	0.000118	0.00136	CcSEcCtD
Guanabenz—Hypertension—Sibutramine—obesity	0.000117	0.00135	CcSEcCtD
Guanabenz—Dry mouth—Orlistat—obesity	0.000117	0.00134	CcSEcCtD
Guanabenz—Flatulence—Bupropion—obesity	0.000117	0.00134	CcSEcCtD
Guanabenz—Dehydration—Topiramate—obesity	0.000117	0.00134	CcSEcCtD
Guanabenz—Tension—Bupropion—obesity	0.000116	0.00133	CcSEcCtD
Guanabenz—Liver function test abnormal—Topiramate—obesity	0.000116	0.00133	CcSEcCtD
Guanabenz—Arthralgia—Sibutramine—obesity	0.000116	0.00133	CcSEcCtD
Guanabenz—Chest pain—Sibutramine—obesity	0.000116	0.00133	CcSEcCtD
Guanabenz—Myalgia—Sibutramine—obesity	0.000116	0.00133	CcSEcCtD
Guanabenz—Anxiety—Sibutramine—obesity	0.000115	0.00132	CcSEcCtD
Guanabenz—Nervousness—Bupropion—obesity	0.000115	0.00132	CcSEcCtD
Guanabenz—Oedema—Orlistat—obesity	0.000115	0.00132	CcSEcCtD
Guanabenz—Back pain—Bupropion—obesity	0.000115	0.00132	CcSEcCtD
Guanabenz—Orthostatic hypotension—Topiramate—obesity	0.000115	0.00131	CcSEcCtD
Guanabenz—Discomfort—Sibutramine—obesity	0.000114	0.00131	CcSEcCtD
Guanabenz—Hypokalaemia—Topiramate—obesity	0.000114	0.00131	CcSEcCtD
Guanabenz—Muscle spasms—Bupropion—obesity	0.000114	0.00131	CcSEcCtD
Guanabenz—Infection—Orlistat—obesity	0.000114	0.00131	CcSEcCtD
Guanabenz—Breast disorder—Topiramate—obesity	0.000113	0.0013	CcSEcCtD
Guanabenz—Dry mouth—Sibutramine—obesity	0.000113	0.0013	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Topiramate—obesity	0.000113	0.0013	CcSEcCtD
Guanabenz—Nervous system disorder—Orlistat—obesity	0.000112	0.00129	CcSEcCtD
Guanabenz—Confusional state—Sibutramine—obesity	0.000112	0.00128	CcSEcCtD
Guanabenz—Vision blurred—Bupropion—obesity	0.000112	0.00128	CcSEcCtD
Guanabenz—Skin disorder—Orlistat—obesity	0.000111	0.00128	CcSEcCtD
Guanabenz—Gastritis—Topiramate—obesity	0.000111	0.00127	CcSEcCtD
Guanabenz—Oedema—Sibutramine—obesity	0.000111	0.00127	CcSEcCtD
Guanabenz—Infection—Sibutramine—obesity	0.00011	0.00126	CcSEcCtD
Guanabenz—Ill-defined disorder—Bupropion—obesity	0.00011	0.00126	CcSEcCtD
Guanabenz—Anaemia—Bupropion—obesity	0.00011	0.00126	CcSEcCtD
Guanabenz—CYP1A2—respiratory system—obesity	0.000109	0.0486	CbGeAlD
Guanabenz—Shock—Sibutramine—obesity	0.000109	0.00125	CcSEcCtD
Guanabenz—Abdominal distension—Topiramate—obesity	0.000109	0.00125	CcSEcCtD
Guanabenz—Agitation—Bupropion—obesity	0.000109	0.00125	CcSEcCtD
Guanabenz—Thrombocytopenia—Sibutramine—obesity	0.000109	0.00125	CcSEcCtD
Guanabenz—Angioedema—Bupropion—obesity	0.000108	0.00124	CcSEcCtD
Guanabenz—Tachycardia—Sibutramine—obesity	0.000108	0.00124	CcSEcCtD
Guanabenz—Skin disorder—Sibutramine—obesity	0.000108	0.00124	CcSEcCtD
Guanabenz—Malaise—Bupropion—obesity	0.000107	0.00123	CcSEcCtD
Guanabenz—ADRA2A—islet of Langerhans—obesity	0.000107	0.0473	CbGeAlD
Guanabenz—Syncope—Bupropion—obesity	0.000106	0.00122	CcSEcCtD
Guanabenz—Leukopenia—Bupropion—obesity	0.000106	0.00122	CcSEcCtD
Guanabenz—ADRA2C—adrenal cortex—obesity	0.000106	0.047	CbGeAlD
Guanabenz—Anorexia—Sibutramine—obesity	0.000106	0.00121	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Orlistat—obesity	0.000104	0.0012	CcSEcCtD
Guanabenz—Loss of consciousness—Bupropion—obesity	0.000104	0.0012	CcSEcCtD
Guanabenz—Abdominal discomfort—Topiramate—obesity	0.000104	0.00119	CcSEcCtD
Guanabenz—Hypotension—Sibutramine—obesity	0.000104	0.00119	CcSEcCtD
Guanabenz—Cough—Bupropion—obesity	0.000103	0.00119	CcSEcCtD
Guanabenz—Paraesthesia—Orlistat—obesity	0.000103	0.00118	CcSEcCtD
Guanabenz—Hypertension—Bupropion—obesity	0.000102	0.00117	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Sibutramine—obesity	0.000101	0.00116	CcSEcCtD
Guanabenz—Dyspepsia—Orlistat—obesity	0.000101	0.00116	CcSEcCtD
Guanabenz—Myalgia—Bupropion—obesity	0.000101	0.00116	CcSEcCtD
Guanabenz—Arthralgia—Bupropion—obesity	0.000101	0.00116	CcSEcCtD
Guanabenz—Chest pain—Bupropion—obesity	0.000101	0.00116	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Topiramate—obesity	0.000101	0.00116	CcSEcCtD
Guanabenz—Anxiety—Bupropion—obesity	0.000101	0.00115	CcSEcCtD
Guanabenz—Discomfort—Bupropion—obesity	9.97e-05	0.00114	CcSEcCtD
Guanabenz—Decreased appetite—Orlistat—obesity	9.97e-05	0.00114	CcSEcCtD
Guanabenz—Paraesthesia—Sibutramine—obesity	9.97e-05	0.00114	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Orlistat—obesity	9.9e-05	0.00114	CcSEcCtD
Guanabenz—Dyspnoea—Sibutramine—obesity	9.89e-05	0.00114	CcSEcCtD
Guanabenz—Fatigue—Orlistat—obesity	9.89e-05	0.00113	CcSEcCtD
Guanabenz—Dry mouth—Bupropion—obesity	9.87e-05	0.00113	CcSEcCtD
Guanabenz—Weight increased—Topiramate—obesity	9.86e-05	0.00113	CcSEcCtD
Guanabenz—Weight decreased—Topiramate—obesity	9.81e-05	0.00113	CcSEcCtD
Guanabenz—Pain—Orlistat—obesity	9.81e-05	0.00113	CcSEcCtD
Guanabenz—Hyperglycaemia—Topiramate—obesity	9.78e-05	0.00112	CcSEcCtD
Guanabenz—Dyspepsia—Sibutramine—obesity	9.77e-05	0.00112	CcSEcCtD
Guanabenz—Confusional state—Bupropion—obesity	9.76e-05	0.00112	CcSEcCtD
Guanabenz—Oedema—Bupropion—obesity	9.67e-05	0.00111	CcSEcCtD
Guanabenz—Infestation NOS—Topiramate—obesity	9.66e-05	0.00111	CcSEcCtD
Guanabenz—Infestation—Topiramate—obesity	9.66e-05	0.00111	CcSEcCtD
Guanabenz—Decreased appetite—Sibutramine—obesity	9.65e-05	0.00111	CcSEcCtD
Guanabenz—Infection—Bupropion—obesity	9.61e-05	0.0011	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Sibutramine—obesity	9.58e-05	0.0011	CcSEcCtD
Guanabenz—Shock—Bupropion—obesity	9.52e-05	0.00109	CcSEcCtD
Guanabenz—Pain—Sibutramine—obesity	9.49e-05	0.00109	CcSEcCtD
Guanabenz—Constipation—Sibutramine—obesity	9.49e-05	0.00109	CcSEcCtD
Guanabenz—Nervous system disorder—Bupropion—obesity	9.49e-05	0.00109	CcSEcCtD
Guanabenz—Thrombocytopenia—Bupropion—obesity	9.47e-05	0.00109	CcSEcCtD
Guanabenz—Feeling abnormal—Orlistat—obesity	9.45e-05	0.00108	CcSEcCtD
Guanabenz—Tachycardia—Bupropion—obesity	9.44e-05	0.00108	CcSEcCtD
Guanabenz—Skin disorder—Bupropion—obesity	9.4e-05	0.00108	CcSEcCtD
Guanabenz—Gastrointestinal pain—Orlistat—obesity	9.38e-05	0.00108	CcSEcCtD
Guanabenz—Anorexia—Bupropion—obesity	9.22e-05	0.00106	CcSEcCtD
Guanabenz—Feeling abnormal—Sibutramine—obesity	9.15e-05	0.00105	CcSEcCtD
Guanabenz—Urticaria—Orlistat—obesity	9.11e-05	0.00105	CcSEcCtD
Guanabenz—Gastrointestinal pain—Sibutramine—obesity	9.07e-05	0.00104	CcSEcCtD
Guanabenz—Body temperature increased—Orlistat—obesity	9.07e-05	0.00104	CcSEcCtD
Guanabenz—Abdominal pain—Orlistat—obesity	9.07e-05	0.00104	CcSEcCtD
Guanabenz—Hypotension—Bupropion—obesity	9.04e-05	0.00104	CcSEcCtD
Guanabenz—Urticaria—Sibutramine—obesity	8.82e-05	0.00101	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Bupropion—obesity	8.81e-05	0.00101	CcSEcCtD
Guanabenz—Abdominal pain—Sibutramine—obesity	8.77e-05	0.00101	CcSEcCtD
Guanabenz—Body temperature increased—Sibutramine—obesity	8.77e-05	0.00101	CcSEcCtD
Guanabenz—Haemoglobin—Topiramate—obesity	8.72e-05	0.001	CcSEcCtD
Guanabenz—Paraesthesia—Bupropion—obesity	8.69e-05	0.000997	CcSEcCtD
Guanabenz—Haemorrhage—Topiramate—obesity	8.68e-05	0.000995	CcSEcCtD
Guanabenz—Dyspnoea—Bupropion—obesity	8.63e-05	0.00099	CcSEcCtD
Guanabenz—ADRA2C—pituitary gland—obesity	8.55e-05	0.038	CbGeAlD
Guanabenz—Oedema peripheral—Topiramate—obesity	8.55e-05	0.000981	CcSEcCtD
Guanabenz—Connective tissue disorder—Topiramate—obesity	8.53e-05	0.000978	CcSEcCtD
Guanabenz—ADRA2C—adipose tissue—obesity	8.52e-05	0.0378	CbGeAlD
Guanabenz—Dyspepsia—Bupropion—obesity	8.52e-05	0.000977	CcSEcCtD
Guanabenz—Hypersensitivity—Orlistat—obesity	8.45e-05	0.000969	CcSEcCtD
Guanabenz—Decreased appetite—Bupropion—obesity	8.41e-05	0.000965	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Bupropion—obesity	8.35e-05	0.000958	CcSEcCtD
Guanabenz—Fatigue—Bupropion—obesity	8.34e-05	0.000957	CcSEcCtD
Guanabenz—Constipation—Bupropion—obesity	8.27e-05	0.000949	CcSEcCtD
Guanabenz—Pain—Bupropion—obesity	8.27e-05	0.000949	CcSEcCtD
Guanabenz—Asthenia—Orlistat—obesity	8.23e-05	0.000944	CcSEcCtD
Guanabenz—Erythema multiforme—Topiramate—obesity	8.2e-05	0.000941	CcSEcCtD
Guanabenz—Hypersensitivity—Sibutramine—obesity	8.18e-05	0.000938	CcSEcCtD
Guanabenz—Pruritus—Orlistat—obesity	8.11e-05	0.000931	CcSEcCtD
Guanabenz—Eye disorder—Topiramate—obesity	8.11e-05	0.00093	CcSEcCtD
Guanabenz—Tinnitus—Topiramate—obesity	8.09e-05	0.000928	CcSEcCtD
Guanabenz—Feeling abnormal—Bupropion—obesity	7.97e-05	0.000915	CcSEcCtD
Guanabenz—Asthenia—Sibutramine—obesity	7.96e-05	0.000914	CcSEcCtD
Guanabenz—Gastrointestinal pain—Bupropion—obesity	7.91e-05	0.000908	CcSEcCtD
Guanabenz—Pruritus—Sibutramine—obesity	7.85e-05	0.000901	CcSEcCtD
Guanabenz—Diarrhoea—Orlistat—obesity	7.85e-05	0.0009	CcSEcCtD
Guanabenz—Immune system disorder—Topiramate—obesity	7.84e-05	0.000899	CcSEcCtD
Guanabenz—Mediastinal disorder—Topiramate—obesity	7.82e-05	0.000897	CcSEcCtD
Guanabenz—Chills—Topiramate—obesity	7.78e-05	0.000893	CcSEcCtD
Guanabenz—Urticaria—Bupropion—obesity	7.69e-05	0.000882	CcSEcCtD
Guanabenz—Abdominal pain—Bupropion—obesity	7.65e-05	0.000877	CcSEcCtD
Guanabenz—Body temperature increased—Bupropion—obesity	7.65e-05	0.000877	CcSEcCtD
Guanabenz—ADRA2C—adrenal gland—obesity	7.64e-05	0.0339	CbGeAlD
Guanabenz—Diarrhoea—Sibutramine—obesity	7.59e-05	0.000871	CcSEcCtD
Guanabenz—Dizziness—Orlistat—obesity	7.58e-05	0.00087	CcSEcCtD
Guanabenz—Erythema—Topiramate—obesity	7.55e-05	0.000867	CcSEcCtD
Guanabenz—Malnutrition—Topiramate—obesity	7.55e-05	0.000867	CcSEcCtD
Guanabenz—Flatulence—Topiramate—obesity	7.44e-05	0.000854	CcSEcCtD
Guanabenz—Tension—Topiramate—obesity	7.41e-05	0.00085	CcSEcCtD
Guanabenz—Dizziness—Sibutramine—obesity	7.34e-05	0.000842	CcSEcCtD
Guanabenz—Nervousness—Topiramate—obesity	7.34e-05	0.000842	CcSEcCtD
Guanabenz—Back pain—Topiramate—obesity	7.31e-05	0.000838	CcSEcCtD
Guanabenz—Vomiting—Orlistat—obesity	7.29e-05	0.000837	CcSEcCtD
Guanabenz—Muscle spasms—Topiramate—obesity	7.26e-05	0.000833	CcSEcCtD
Guanabenz—Rash—Orlistat—obesity	7.23e-05	0.00083	CcSEcCtD
Guanabenz—Dermatitis—Orlistat—obesity	7.22e-05	0.000829	CcSEcCtD
Guanabenz—Headache—Orlistat—obesity	7.18e-05	0.000824	CcSEcCtD
Guanabenz—Hypersensitivity—Bupropion—obesity	7.13e-05	0.000818	CcSEcCtD
Guanabenz—Vision blurred—Topiramate—obesity	7.12e-05	0.000817	CcSEcCtD
Guanabenz—Vomiting—Sibutramine—obesity	7.06e-05	0.00081	CcSEcCtD
Guanabenz—Ill-defined disorder—Topiramate—obesity	7.01e-05	0.000804	CcSEcCtD
Guanabenz—Rash—Sibutramine—obesity	7e-05	0.000803	CcSEcCtD
Guanabenz—Dermatitis—Sibutramine—obesity	6.99e-05	0.000802	CcSEcCtD
Guanabenz—Anaemia—Topiramate—obesity	6.98e-05	0.000801	CcSEcCtD
Guanabenz—CYP1A2—digestive system—obesity	6.96e-05	0.0309	CbGeAlD
Guanabenz—Headache—Sibutramine—obesity	6.95e-05	0.000798	CcSEcCtD
Guanabenz—Asthenia—Bupropion—obesity	6.94e-05	0.000796	CcSEcCtD
Guanabenz—Agitation—Topiramate—obesity	6.94e-05	0.000796	CcSEcCtD
Guanabenz—Pruritus—Bupropion—obesity	6.85e-05	0.000785	CcSEcCtD
Guanabenz—ADRA2A—pituitary gland—obesity	6.82e-05	0.0303	CbGeAlD
Guanabenz—Nausea—Orlistat—obesity	6.81e-05	0.000781	CcSEcCtD
Guanabenz—Malaise—Topiramate—obesity	6.81e-05	0.000781	CcSEcCtD
Guanabenz—ADRA2A—adipose tissue—obesity	6.8e-05	0.0302	CbGeAlD
Guanabenz—Syncope—Topiramate—obesity	6.77e-05	0.000777	CcSEcCtD
Guanabenz—Leukopenia—Topiramate—obesity	6.76e-05	0.000776	CcSEcCtD
Guanabenz—Loss of consciousness—Topiramate—obesity	6.64e-05	0.000762	CcSEcCtD
Guanabenz—Diarrhoea—Bupropion—obesity	6.62e-05	0.000759	CcSEcCtD
Guanabenz—Nausea—Sibutramine—obesity	6.59e-05	0.000756	CcSEcCtD
Guanabenz—Cough—Topiramate—obesity	6.59e-05	0.000756	CcSEcCtD
Guanabenz—Hypertension—Topiramate—obesity	6.52e-05	0.000748	CcSEcCtD
Guanabenz—Chest pain—Topiramate—obesity	6.43e-05	0.000738	CcSEcCtD
Guanabenz—Arthralgia—Topiramate—obesity	6.43e-05	0.000738	CcSEcCtD
Guanabenz—Myalgia—Topiramate—obesity	6.43e-05	0.000738	CcSEcCtD
Guanabenz—Anxiety—Topiramate—obesity	6.41e-05	0.000735	CcSEcCtD
Guanabenz—Dizziness—Bupropion—obesity	6.4e-05	0.000734	CcSEcCtD
Guanabenz—Discomfort—Topiramate—obesity	6.35e-05	0.000729	CcSEcCtD
Guanabenz—Dry mouth—Topiramate—obesity	6.29e-05	0.000721	CcSEcCtD
Guanabenz—Confusional state—Topiramate—obesity	6.22e-05	0.000713	CcSEcCtD
Guanabenz—Oedema—Topiramate—obesity	6.16e-05	0.000707	CcSEcCtD
Guanabenz—Vomiting—Bupropion—obesity	6.15e-05	0.000706	CcSEcCtD
Guanabenz—Infection—Topiramate—obesity	6.12e-05	0.000703	CcSEcCtD
Guanabenz—Rash—Bupropion—obesity	6.1e-05	0.0007	CcSEcCtD
Guanabenz—ADRA2A—adrenal gland—obesity	6.1e-05	0.0271	CbGeAlD
Guanabenz—Dermatitis—Bupropion—obesity	6.09e-05	0.000699	CcSEcCtD
Guanabenz—Shock—Topiramate—obesity	6.06e-05	0.000696	CcSEcCtD
Guanabenz—Headache—Bupropion—obesity	6.06e-05	0.000695	CcSEcCtD
Guanabenz—Nervous system disorder—Topiramate—obesity	6.04e-05	0.000694	CcSEcCtD
Guanabenz—Thrombocytopenia—Topiramate—obesity	6.04e-05	0.000692	CcSEcCtD
Guanabenz—Tachycardia—Topiramate—obesity	6.02e-05	0.00069	CcSEcCtD
Guanabenz—Skin disorder—Topiramate—obesity	5.99e-05	0.000687	CcSEcCtD
Guanabenz—ADRA2C—liver—obesity	5.97e-05	0.0265	CbGeAlD
Guanabenz—Anorexia—Topiramate—obesity	5.88e-05	0.000674	CcSEcCtD
Guanabenz—Hypotension—Topiramate—obesity	5.76e-05	0.000661	CcSEcCtD
Guanabenz—CYP1A2—endocrine gland—obesity	5.75e-05	0.0255	CbGeAlD
Guanabenz—Nausea—Bupropion—obesity	5.75e-05	0.000659	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Topiramate—obesity	5.62e-05	0.000644	CcSEcCtD
Guanabenz—Paraesthesia—Topiramate—obesity	5.53e-05	0.000635	CcSEcCtD
Guanabenz—Dyspnoea—Topiramate—obesity	5.5e-05	0.00063	CcSEcCtD
Guanabenz—Dyspepsia—Topiramate—obesity	5.43e-05	0.000623	CcSEcCtD
Guanabenz—Decreased appetite—Topiramate—obesity	5.36e-05	0.000615	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Topiramate—obesity	5.32e-05	0.000611	CcSEcCtD
Guanabenz—Fatigue—Topiramate—obesity	5.31e-05	0.00061	CcSEcCtD
Guanabenz—ADRA2A—endocrine gland—obesity	5.29e-05	0.0235	CbGeAlD
Guanabenz—Pain—Topiramate—obesity	5.27e-05	0.000605	CcSEcCtD
Guanabenz—Constipation—Topiramate—obesity	5.27e-05	0.000605	CcSEcCtD
Guanabenz—CYP1A2—liver—obesity	5.18e-05	0.023	CbGeAlD
Guanabenz—Feeling abnormal—Topiramate—obesity	5.08e-05	0.000583	CcSEcCtD
Guanabenz—Gastrointestinal pain—Topiramate—obesity	5.04e-05	0.000578	CcSEcCtD
Guanabenz—Urticaria—Topiramate—obesity	4.9e-05	0.000562	CcSEcCtD
Guanabenz—Body temperature increased—Topiramate—obesity	4.87e-05	0.000559	CcSEcCtD
Guanabenz—Abdominal pain—Topiramate—obesity	4.87e-05	0.000559	CcSEcCtD
Guanabenz—Hypersensitivity—Topiramate—obesity	4.54e-05	0.000521	CcSEcCtD
Guanabenz—Asthenia—Topiramate—obesity	4.42e-05	0.000507	CcSEcCtD
Guanabenz—Pruritus—Topiramate—obesity	4.36e-05	0.0005	CcSEcCtD
Guanabenz—Diarrhoea—Topiramate—obesity	4.22e-05	0.000484	CcSEcCtD
Guanabenz—Dizziness—Topiramate—obesity	4.08e-05	0.000468	CcSEcCtD
Guanabenz—Vomiting—Topiramate—obesity	3.92e-05	0.00045	CcSEcCtD
Guanabenz—Rash—Topiramate—obesity	3.89e-05	0.000446	CcSEcCtD
Guanabenz—Dermatitis—Topiramate—obesity	3.88e-05	0.000445	CcSEcCtD
Guanabenz—Headache—Topiramate—obesity	3.86e-05	0.000443	CcSEcCtD
Guanabenz—Nausea—Topiramate—obesity	3.66e-05	0.00042	CcSEcCtD
Guanabenz—ADRA2A—Signaling Pathways—PRL—obesity	4.22e-06	7.57e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PRKCD—obesity	4.21e-06	7.56e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SULT2A1—obesity	4.21e-06	7.56e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GLP1R—obesity	4.21e-06	7.56e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CB—obesity	4.19e-06	7.52e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STK11—obesity	4.16e-06	7.46e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—LPL—obesity	4.15e-06	7.45e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—DPYD—obesity	4.14e-06	7.44e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—CCL2—obesity	4.14e-06	7.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—HTR2A—obesity	4.12e-06	7.4e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—C3—obesity	4.12e-06	7.39e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PLG—obesity	4.11e-06	7.38e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—RHOA—obesity	4.11e-06	7.37e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT2—obesity	4.07e-06	7.3e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3R1—obesity	4.06e-06	7.29e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GPX1—obesity	4.05e-06	7.27e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FOXO3—obesity	4.01e-06	7.2e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADRB2—obesity	4e-06	7.18e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PRKAR2B—obesity	3.99e-06	7.16e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—DCN—obesity	3.96e-06	7.11e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CD36—obesity	3.94e-06	7.08e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SOCS1—obesity	3.94e-06	7.07e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PRKCD—obesity	3.94e-06	7.06e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IRS2—obesity	3.92e-06	7.03e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AGT—obesity	3.91e-06	7.02e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CD—obesity	3.91e-06	7.01e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT1—obesity	3.89e-06	6.99e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SOCS3—obesity	3.89e-06	6.99e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	3.89e-06	6.98e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CG—obesity	3.87e-06	6.94e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CPT1A—obesity	3.85e-06	6.91e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—HTR2A—obesity	3.85e-06	6.91e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—C3—obesity	3.85e-06	6.9e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LEP—obesity	3.83e-06	6.88e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOE—obesity	3.83e-06	6.88e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GNB3—obesity	3.81e-06	6.84e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CAV1—obesity	3.8e-06	6.82e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—APOA1—obesity	3.79e-06	6.8e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NAMPT—obesity	3.78e-06	6.78e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—TYK2—obesity	3.76e-06	6.74e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	3.76e-06	6.74e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCK—obesity	3.75e-06	6.74e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LIPC—obesity	3.75e-06	6.74e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CB—obesity	3.75e-06	6.73e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF2—obesity	3.74e-06	6.72e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MTHFR—obesity	3.74e-06	6.71e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOC3—obesity	3.73e-06	6.7e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—obesity	3.73e-06	6.69e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—RHOA—obesity	3.73e-06	6.69e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GNAS—obesity	3.71e-06	6.66e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	3.7e-06	6.65e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3R1—obesity	3.69e-06	6.62e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—POMC—obesity	3.68e-06	6.6e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARA—obesity	3.67e-06	6.58e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ESR1—obesity	3.66e-06	6.57e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IRS2—obesity	3.66e-06	6.57e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—INS—obesity	3.66e-06	6.57e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AGT—obesity	3.66e-06	6.56e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT1—obesity	3.64e-06	6.53e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOB—obesity	3.63e-06	6.52e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CETP—obesity	3.62e-06	6.5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—PIK3CA—obesity	3.62e-06	6.49e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PRKCB—obesity	3.62e-06	6.49e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—F2—obesity	3.62e-06	6.49e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SDC1—obesity	3.58e-06	6.43e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LEP—obesity	3.58e-06	6.43e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOE—obesity	3.58e-06	6.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—BAD—obesity	3.57e-06	6.41e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AGT—obesity	3.55e-06	6.37e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL5—obesity	3.55e-06	6.37e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CAV1—obesity	3.55e-06	6.37e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—APOA1—obesity	3.54e-06	6.35e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKR1C3—obesity	3.52e-06	6.32e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOE—obesity	3.48e-06	6.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LPL—obesity	3.47e-06	6.23e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SCARB1—obesity	3.47e-06	6.22e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CG—obesity	3.46e-06	6.21e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CAV1—obesity	3.45e-06	6.18e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FOXO1—obesity	3.45e-06	6.18e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RPS6KB1—obesity	3.44e-06	6.17e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—APOA1—obesity	3.44e-06	6.17e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.42e-06	6.14e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IRS1—obesity	3.42e-06	6.14e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ESR1—obesity	3.42e-06	6.14e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CB—obesity	3.41e-06	6.11e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CD—obesity	3.4e-06	6.1e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—F2—obesity	3.38e-06	6.06e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PRKCB—obesity	3.38e-06	6.06e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	3.38e-06	6.06e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SREBF1—obesity	3.37e-06	6.04e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—ALB—obesity	3.35e-06	6.02e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—BAD—obesity	3.34e-06	5.99e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—POMC—obesity	3.29e-06	5.91e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GOT2—obesity	3.28e-06	5.88e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—INS—obesity	3.28e-06	5.88e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CG—obesity	3.23e-06	5.8e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.23e-06	5.8e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—CCL2—obesity	3.22e-06	5.78e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3R1—obesity	3.21e-06	5.76e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NOS3—obesity	3.21e-06	5.76e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—FASN—obesity	3.21e-06	5.75e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCD—obesity	3.2e-06	5.74e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IRS1—obesity	3.2e-06	5.73e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—BCHE—obesity	3.19e-06	5.73e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—obesity	3.17e-06	5.68e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT2—obesity	3.17e-06	5.68e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CG—obesity	3.14e-06	5.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—HTR2A—obesity	3.13e-06	5.61e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—C3—obesity	3.12e-06	5.61e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP2E1—obesity	3.08e-06	5.53e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—POMC—obesity	3.08e-06	5.52e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—INS—obesity	3.06e-06	5.49e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NQO1—obesity	3.05e-06	5.46e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CD—obesity	3.04e-06	5.46e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—obesity	3.03e-06	5.44e-05	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—PIK3CA—obesity	3.01e-06	5.41e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—CCL2—obesity	3.01e-06	5.4e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SERPINE1—obesity	3.01e-06	5.4e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—POMC—obesity	2.99e-06	5.36e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.98e-06	5.35e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IRS2—obesity	2.97e-06	5.33e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—INS—obesity	2.97e-06	5.33e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AGT—obesity	2.97e-06	5.33e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CB—obesity	2.96e-06	5.31e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—obesity	2.96e-06	5.31e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT2—obesity	2.96e-06	5.31e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT1—obesity	2.96e-06	5.3e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.95e-06	5.3e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PTGS2—obesity	2.93e-06	5.27e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TYK2—obesity	2.93e-06	5.25e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GCG—obesity	2.92e-06	5.24e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC2A4—obesity	2.92e-06	5.24e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOE—obesity	2.91e-06	5.22e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LEP—obesity	2.91e-06	5.22e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RHOA—obesity	2.9e-06	5.21e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CAV1—obesity	2.88e-06	5.17e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYCS—obesity	2.88e-06	5.17e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—APOA1—obesity	2.88e-06	5.16e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3R1—obesity	2.87e-06	5.15e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NOS3—obesity	2.87e-06	5.15e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CD—obesity	2.84e-06	5.1e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GGT1—obesity	2.83e-06	5.07e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GOT1—obesity	2.83e-06	5.07e-05	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	2.81e-06	5.05e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SERPINE1—obesity	2.81e-06	5.04e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NCOA1—obesity	2.79e-06	5e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ESR1—obesity	2.78e-06	4.98e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CD—obesity	2.76e-06	4.95e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—STK11—obesity	2.75e-06	4.93e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP19A1—obesity	2.75e-06	4.93e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—F2—obesity	2.74e-06	4.92e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRKCB—obesity	2.74e-06	4.92e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—PIK3CA—obesity	2.74e-06	4.91e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TYK2—obesity	2.73e-06	4.9e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—ALB—obesity	2.72e-06	4.89e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RHOA—obesity	2.71e-06	4.86e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—BAD—obesity	2.71e-06	4.86e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NOS3—obesity	2.68e-06	4.81e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3R1—obesity	2.68e-06	4.81e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CB—obesity	2.65e-06	4.76e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MTOR—obesity	2.65e-06	4.76e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CG—obesity	2.63e-06	4.71e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NOS3—obesity	2.61e-06	4.68e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3R1—obesity	2.61e-06	4.68e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IRS1—obesity	2.6e-06	4.66e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—PIK3CA—obesity	2.56e-06	4.59e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—COMT—obesity	2.55e-06	4.58e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARGC1A—obesity	2.52e-06	4.52e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GNB3—obesity	2.52e-06	4.52e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMOX1—obesity	2.51e-06	4.49e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—POMC—obesity	2.5e-06	4.48e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—INS—obesity	2.49e-06	4.46e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CB—obesity	2.48e-06	4.44e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MTOR—obesity	2.48e-06	4.44e-05	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT1—obesity	2.46e-06	4.42e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GNAS—obesity	2.45e-06	4.4e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—CCL2—obesity	2.45e-06	4.39e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—obesity	2.42e-06	4.35e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CB—obesity	2.41e-06	4.32e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—obesity	2.4e-06	4.31e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT2—obesity	2.4e-06	4.31e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOB—obesity	2.4e-06	4.31e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PTGS2—obesity	2.38e-06	4.28e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CD—obesity	2.31e-06	4.14e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MMP9—obesity	2.3e-06	4.14e-05	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT1—obesity	2.3e-06	4.13e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPL—obesity	2.29e-06	4.11e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	2.29e-06	4.1e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SERPINE1—obesity	2.28e-06	4.1e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—obesity	2.26e-06	4.06e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MAPK8—obesity	2.24e-06	4.02e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GPX1—obesity	2.24e-06	4.01e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT1—obesity	2.24e-06	4.01e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TYK2—obesity	2.22e-06	3.98e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RHOA—obesity	2.2e-06	3.95e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NOS3—obesity	2.18e-06	3.91e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3R1—obesity	2.18e-06	3.91e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CD36—obesity	2.18e-06	3.91e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MMP9—obesity	2.15e-06	3.86e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MAPK8—obesity	2.09e-06	3.76e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT1—obesity	2.09e-06	3.75e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—PIK3CA—obesity	2.08e-06	3.72e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTHFR—obesity	2.06e-06	3.7e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—STAT3—obesity	2.05e-06	3.68e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARA—obesity	2.02e-06	3.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CB—obesity	2.01e-06	3.61e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MTOR—obesity	2.01e-06	3.61e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AGT—obesity	1.96e-06	3.52e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOE—obesity	1.92e-06	3.45e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—STAT3—obesity	1.91e-06	3.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MYC—obesity	1.9e-06	3.42e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CAV1—obesity	1.9e-06	3.41e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TGFB1—obesity	1.9e-06	3.41e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—APOA1—obesity	1.9e-06	3.41e-05	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT1—obesity	1.87e-06	3.35e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—obesity	1.84e-06	3.3e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.82e-06	3.26e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PIK3CA—obesity	1.81e-06	3.24e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MYC—obesity	1.78e-06	3.19e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TGFB1—obesity	1.77e-06	3.18e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MMP9—obesity	1.75e-06	3.14e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CG—obesity	1.73e-06	3.11e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MAPK8—obesity	1.7e-06	3.05e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT1—obesity	1.7e-06	3.04e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—obesity	1.67e-06	3e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—POMC—obesity	1.65e-06	2.96e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—INS—obesity	1.64e-06	2.94e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PIK3CA—obesity	1.62e-06	2.9e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—STAT3—obesity	1.55e-06	2.79e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CD—obesity	1.52e-06	2.73e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PIK3CA—obesity	1.51e-06	2.71e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ALB—obesity	1.5e-06	2.7e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKT1—obesity	1.48e-06	2.65e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PIK3CA—obesity	1.47e-06	2.63e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MYC—obesity	1.44e-06	2.59e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TGFB1—obesity	1.44e-06	2.59e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NOS3—obesity	1.44e-06	2.58e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3R1—obesity	1.44e-06	2.58e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—obesity	1.43e-06	2.57e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—obesity	1.34e-06	2.4e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CB—obesity	1.33e-06	2.38e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT1—obesity	1.32e-06	2.37e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PTGS2—obesity	1.32e-06	2.36e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT1—obesity	1.23e-06	2.21e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PIK3CA—obesity	1.23e-06	2.2e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKT1—obesity	1.2e-06	2.15e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—obesity	1.09e-06	1.95e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT1—obesity	1e-06	1.8e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PIK3CA—obesity	8.1e-07	1.45e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKT1—obesity	6.61e-07	1.19e-05	CbGpPWpGaD
